Characterization of Subtype Selective Cannabinoid CB<sub>2</sub> Receptor Agonists as Potential Anti-Inflammatory Agents
Activation of the CB<sub>2</sub> receptor has been shown to have anti-inflammatory and antinociceptive effects without causing psychoactive effects. Previously, we reported that the compound ethyl 2(2-(<i>N</i>-(2,3-dimethylphenyl) phenylsulfonamido)acetamido)benzoate (ABK5)...
Saved in:
Main Authors: | Yaliang Tang (Author), Barbara Wolk (Author), Ryan Nolan (Author), Caitlin E. Scott (Author), Debra A. Kendall (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
by: Yaliang Tang, et al.
Published: (2021) -
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019) -
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023) -
Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023) -
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
by: David B. Finlay, et al.
Published: (2022)